Here are five healthcare themes to watch next year, and which stocks stand to benefit. Key names to watch include Eli Lilly, ...

With generic rivals waiting in the wings, Eli Lilly and Novo Nordisk are intensifying efforts to lock in market share in India’s rapidly expanding obesity drug market, turning pricing, promotion, and ...

President Trump signed an order dropping cannabis from Schedule I to Schedule III. What happens next is crucial. Most needed: ...

Chinese biotech innovator Jacobio Pharma has struck a global out-licensing deal with pharmaceutical giant AstraZeneca for a promising cancer drug, marking one of the largest cross-border transactions ...

Omeros (OMER) receives FDA approval for Yartemlea (narsoplimab) in TA-TMA, driving shares up nearly 80% to a $1bn+ valuation.

The next transformative phase of weight-loss medication is upon us, with the US Food and Drug Administration (FDA) approving ...

Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market ...

About ReNu® ReNu is a cryopreserved, amniotic suspension allograft developed for the management of symptomatic knee osteoarthritis. ReNu consists of amniotic fluid cells and micronized amniotic ...

A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for ...

The inspector general report suggests that a new mandate in Republicans’ One Big Beautiful Bill could help reduce these kind ...

The U.S. Food and Drug Administration's approval of an oral version of Novo Nordisk's weight-loss drug Wegovy could ...

The Centers for Medicare & Medicaid Services released details of its proposal to address the expensive costs of Medicare Part B.